Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells
- 1 July 2019
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 26 (6) , 835-845
Abstract
FAM64A is a mitotic regulator promoting cell metaphase–anaphase transition, and it is frequently reported to be highly expressed in cancer cells. However, the role of FAM64A in human breast cancer (BrC) is poorly studied.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2015A030310100)
This publication has 26 references indexed in Scilit:
- Targeting cell cycle regulation in cancer therapyPharmacology & Therapeutics, 2013
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant TamoxifenClinical Cancer Research, 2012
- The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancerBreast Cancer, 2010
- RCS1, a substrate of APC/C, controls the metaphase to anaphase transitionProceedings of the National Academy of Sciences, 2008
- The CALM and CALM/AF10 interactor CATS is a marker for proliferationMolecular Oncology, 2008
- Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signaturesBreast Cancer Research, 2008
- Twist is a transcriptional repressor of E-cadherin gene expression in breast cancerBiochemical and Biophysical Research Communications, 2008
- Vimentin and Epithelial-Mesenchymal Transition in Human Breast Cancer – Observations in vitro and in vivoCells Tissues Organs, 2007
- The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10Oncogene, 2006
- The Hallmarks of CancerCell, 2000